AML-SCORE for estimating the chance of a complete remission and the risk of an early death in elderly patients with acute myeloid leukemia (AML) after intensive induction therapy.
SAL Study Alliance Leukemia
AMLCG

Welcome to the webpage of www.aml-score.org

This webpage contains an online tool to estimate the chance of achieving a complete remission and the risk of early death within 60 days after an intensive induction therapy in patients of 60 years of age or older with previously untreated AML.

These scores are based on pre-therapeutic clinical and, if available, cytogenetic and molecular parameters. The scores herein are calculated according to the underlying algorithms as presented at the 52nd meeting of the American Society of Hematology [1] and published [2].


User login

Enter your username and password here in order to log in on the website. You have to register first – choose "registration" from the menu on the left side.
Login

Forgot your password?



Registration